What is the appropriate workup for an 18-year-old patient suspected of having Marfan syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Suspected Marfan Syndrome in an 18-Year-Old

Order a transthoracic echocardiogram immediately to measure the aortic root at the sinuses of Valsalva, sinotubular junction, and ascending aorta with Z-score calculation, and arrange a dilated ophthalmologic examination to assess for ectopia lentis—these two cardinal features, along with systemic scoring and family history, form the foundation of the revised Ghent diagnostic criteria. 1

Immediate Cardiovascular Assessment

  • Obtain transthoracic echocardiography (TTE) without delay, measuring the aortic annulus, sinuses of Valsalva (the most critical segment), sinotubular junction, and ascending aorta 1, 2
  • Calculate Z-scores to determine if aortic root diameter exceeds 2 standard deviations above the mean for age, sex, and body surface area 1
  • If TTE does not adequately visualize the entire thoracic aorta, obtain cardiac-gated CT or MRI of the complete thoracic aorta 1, 2
  • In adults, consider CT or MRI after the initial TTE to confirm aortic dimensions and assess the remainder of the thoracic aorta 1, 2

Ophthalmologic Evaluation

  • Perform a dilated slit-lamp examination by an ophthalmologist to detect ectopia lentis (lens dislocation), which is a cardinal diagnostic feature 1, 2
  • The presence of ectopia lentis together with aortic root dilation (Z-score >2) establishes the diagnosis even without other features 1, 2
  • Also assess for myopia >3 diopters, which contributes 1 point to the systemic score 1, 2

Systemic Feature Assessment and Scoring

Apply the revised Ghent systemic scoring system by examining for the following features 1, 2:

Feature Points
Wrist AND thumb sign (both positive) 3 points
Wrist OR thumb sign (only one positive) 1 point
Pectus carinatum deformity 2 points
Pectus excavatum or chest asymmetry 1 point
Hindfoot deformity (severe valgus) 2 points
Plain pes planus (flat feet) 1 point
Pneumothorax (history or current) 2 points
Dural ectasia (on imaging) 2 points
Protrusio acetabuli (on imaging) 2 points
Scoliosis or thoracolumbar kyphosis 1 point
Reduced elbow extension (<170°) 1 point
Facial features (≥3 of 5: dolichocephaly, enophthalmos, downslanting palpebral fissures, malar hypoplasia, retrognathia) 1 point
Skin striae 1 point
Myopia >3 diopters 1 point
Mitral valve prolapse 1 point
  • A systemic score ≥7 points indicates "multiple systemic features" and, when combined with aortic root dilation (Z-score >2), confirms Marfan syndrome in the absence of a family history 1, 2

Detailed Family History

  • Obtain a three-generation pedigree focusing on sudden death, aortic dissection, aortic aneurysm, ectopia lentis, and skeletal features 1, 3
  • If a first-degree relative has independently confirmed Marfan syndrome, the diagnostic threshold is lower: the patient qualifies with ectopia lentis alone, multiple systemic features (≥7 points) alone, or aortic root Z-score >3 (if under 20 years) or >2 (if over 20 years) 1
  • Screen all first-degree relatives with TTE regardless of genetic testing results 2, 4

Diagnostic Criteria Summary (Revised Ghent Nosology)

Without a Family History of Marfan Syndrome:

The diagnosis is established by any one of the following 1, 2:

  1. Aortic root dilation (Z-score ≥2) AND ectopia lentis
  2. Aortic root dilation (Z-score ≥2) AND a pathogenic FBN1 mutation
  3. Aortic root dilation (Z-score ≥2) AND systemic score ≥7
  4. Ectopia lentis AND an FBN1 mutation previously associated with aortic disease

With a Positive Family History:

The diagnosis is established by any one of the following 1:

  1. Ectopia lentis
  2. Systemic score ≥7
  3. Aortic root Z-score >2 (if age >20 years) or >3 (if age <20 years)

Genetic Testing

  • FBN1 gene sequencing is reserved for equivocal cases where clinical criteria are not fully met 1, 2
  • Current molecular testing detects mutations in only 90–95% of unequivocal Marfan syndrome cases, so Marfan syndrome remains primarily a clinical diagnosis 1, 2
  • Consider comprehensive gene panel testing (FBN1, TGFBR1, TGFBR2, COL3A1, ACTA2, MYH11) if the clinical picture suggests an alternative connective tissue disorder such as Loeys-Dietz syndrome or vascular Ehlers-Danlos syndrome 4
  • A pathogenic FBN1 mutation, when combined with aortic root dilation or ectopia lentis, confirms the diagnosis and mandates immediate cardiovascular management 2

Additional Imaging for Specific Indications

  • Lumbar spine MRI to assess for dural ectasia (contributes 2 points to systemic score) if back pain or neurologic symptoms are present 1, 2
  • Pelvic radiograph or CT to evaluate for protrusio acetabuli (contributes 2 points) if hip pain or limited range of motion is noted 1
  • Chest radiograph to document pneumothorax history (contributes 2 points) 1

Differential Diagnosis Considerations

Evaluate for alternative or overlapping diagnoses that share features with Marfan syndrome 1:

  • Loeys-Dietz syndrome (TGFBR1/2 mutations): Look for bifid uvula, cleft palate, craniosynostosis, hypertelorism, and arterial tortuosity; these patients have a much higher dissection risk at smaller aortic diameters (≥4.0–4.5 cm) 1, 4
  • Ehlers-Danlos syndrome (hypermobile type): Assess for joint hypermobility (Beighton score ≥5/9), skin hyperextensibility, easy bruising, and chronic pain; mild aortic root dilation may occur but dissection risk without significant dilation is low 1
  • Familial thoracic aortic aneurysm and dissection (FTAAD): Consider if there is isolated aortic disease without major skeletal or ocular features; exclude bicuspid aortic valve on TTE 1
  • Bicuspid aortic valve sequence: Carefully assess valve morphology on TTE, as 20–84% of individuals with bicuspid aortic valve develop aortic dilation 5

Common Pitfalls to Avoid

  • Do not dismiss the diagnosis based on a negative FBN1 test alone; 5–10% of patients meeting clinical criteria have no detectable mutation 1, 2
  • Do not rely solely on absolute aortic diameter measurements; always calculate Z-scores indexed to body surface area and height, especially in tall patients, to avoid underestimating dissection risk 1, 5
  • Do not overlook ectopia lentis; it is present in approximately 60% of Marfan patients and is a cardinal diagnostic feature that requires specialized ophthalmologic examination 1, 3
  • Do not delay cardiovascular imaging if skeletal features are prominent; aortic dissection can occur even in young patients with normal-appearing aortic dimensions on initial screening 1
  • Do not confuse joint hypermobility in Ehlers-Danlos syndrome with Marfan syndrome; use the Beighton scale (≥5/9 points) to distinguish hypermobile EDS, which has a different natural history and lower cardiovascular risk 1

Immediate Management if Diagnosis is Confirmed

  • Initiate beta-blocker therapy immediately (regardless of aortic size) to slow aortic dilation and reduce dissection risk; titrate to a resting heart rate of 60–70 bpm 1, 2
  • Establish a surveillance imaging protocol: annual TTE if aortic root <4.5 cm and growth <0.5 cm/year; TTE every 6 months if aortic root ≥4.5 cm or growth ≥0.5 cm/year 1, 2
  • Refer to cardiology and cardiovascular surgery for co-management and surgical planning; prophylactic aortic root replacement is indicated at ≥4.5 cm in Marfan syndrome 1, 2
  • Restrict high-intensity isometric exercise and competitive contact sports due to sudden blood-pressure spikes that increase dissection risk; encourage moderate aerobic activity 2, 5
  • Arrange genetic counseling for the patient and family members, as Marfan syndrome follows autosomal dominant inheritance with 50% transmission risk 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guidelines for Management of Marfan Syndrome with a Positive FBN1 Genetic Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Marfan syndrome: clinical diagnosis and management.

European journal of human genetics : EJHG, 2007

Guideline

Genetic Diagnosis and Management of Connective Tissue Disorders Related to Aneurysms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Surgical Thresholds and Management of Dilated Aortic Root in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.